ClinicalTrials.Veeva

Menu

ANRS 12415 - Quali PrEP Cambodia

F

French Public Scientific and Technological Institution (EPST)

Status

Completed

Conditions

Hiv

Treatments

Other: Qualitative assessment about PrEP acceptability

Study type

Observational

Funder types

Other

Identifiers

NCT05091489
PREP2021-MF

Details and patient eligibility

About

Hypothesis:

  • Hypothesis 1 : Regarding the recentness of preexposure prophylaxis (PrEP) implementation with an uptake of 20% and according to the first consultative meeting, awareness and acceptability of PrEP seems to be low in key-populations of Cambodia
  • Hypothesis 2 : Individual, social and structural barriers and facilitating factors of PrEP implementation as perceived by health workers and community-based organizations would be similar to what was observed worldwide 4,8.
  • Hypothesis 3: Some subgroups of key-populations are difficult to reach in health facilities. Community organizations can play a critical role to provide PrEP information, initiation and counselling with the support of new technologies.
  • Hypothesis 4: Community organizations might lack financial, logistical and skill capacities to deliver PrEP in good conditions

Main objective:

• To qualitatively evaluate the knowledge, awareness, perception, experience and acceptability of PrEP among key populations (entertainment workers (EW), men who have sex with men (MSM), transgender women (TW)), and among healthcare and community workers in charge of key populations

Secondary objectives:

  • To better understand the characteristics, needs and expectations of community-based organizations (CBOs), in order to define the optimal conditions for community-based PrEP implementation
  • To identify tools that could be useful to increase PrEP awareness and acceptability, especially new technologies (apps, websites)

Methodology: Qualitative study Focus groups with key-populations, healthcare and community workers Semi-directive interviews with decision makers and policy makers Estimated enrolment: 10 participants per focus group, 8 focus groups, 80 participants in focus groups, 6 interviewed persons, 86 participants in total

Study population: Men who have sex with men (MSM), entertainment workers (EW), transgender women (TGW), healthcare workers, community workers, decision and policy makers

Enrollment

88 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Eligibility criteria for key-populations included in focus groups

  • All key-populations

    • Having consented to participate into the research
    • Self-declared negative HIV status
  • Men who have sex with men (MSM): being sexually active and having had anal sex with at least one male (including TGW women) partner in the past 12 months.

  • Transgender women (TGW): Being biologically male at birth and self-identified as a woman or third gender, reporting having anal sex with at least one male in the past 12 months

  • Male entertainment workers (MEW): having at least one sexual intercourse in exchange of money in the last month. MEW are engaged in transactional sex by Facebook, via online App (Grinder, Blue) and massage parlor.

  • Female entertainment workers: Venue-based (work in entertainment establishment) or non-venue based (freelance/street-based or park-based) women having at least one sexual intercourse in exchange of money in the last month. Venue-based EW (VEW) are defined as EW engaged in transactional sex for supplementary income which are employees in entertainment venues such as karaokes, bars, beer gardens, massage parlours. Free-lance EW (FEW) are defined as EW engaged in transactional sex in short-time hotel or public parks21 or "high-class" EW working in salons or using apps such as Line. We hypothesized that FEW and VEW have different sex behaviours as well as different perceptions and motivations towards PrEP.

  • PrEP users: MSM or TGW who have started medical PrEP in the pilot program "Khmer PrEP" and MSM or TGW who have independently started medical PrEP in private. If possible, individuals who are currently receiving PrEP and individuals who discontinued will be included.

Exclusion criteria for key-populations : self-declared HIV-positive

Eligibility criteria for community and health workers

  • Health workers and counselors: 1/ currently working in a HIV service targeting key populations (Samdach Ov Referral Hospital, Meanchey Referral Hospital, Social Health Clinic). 2/ currently working in a health service delivering PrEP (Chhouk Sar Clinic, Pochentong and Chaktomuk hospitals, RHAC)
  • Community workers: currently working in CBOs with EW, TG and/or MSM (Cambodian Women for Peace and Development (CWPD), Men's Health Cambodia (MHC), Men's Health Social Service (MHSS)

Individual semi-directive interviews will be conducted:

  • NCHADS (operational unit of the Ministry of Health in charge of health sector policy development for HIV/AIDS)
  • National Aids Authority: in charge to lead, manage, coordinate and facilitate the comprehensive and multi-sectoral response to HIV and AIDS in Cambodia
  • Ministry of Health
  • Key influencer in the MSM and/or TG community
  • Key influencer in the EW community
  • Khana : an umbrella organization belonging to the HIV/AIDS international Alliance.
  • High class and hidden MSM
  • Discontinued PrEP user

Trial design

88 participants in 16 patient groups

Men who have sex with men (MSM) non-using PrEP
Description:
Focus group (10 persons)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Male entertainment workers
Description:
Focus group (10 persons)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Free-lance based entertainment female workers non-using PrEP
Description:
Focus group (10 persons)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Venue-based entertainment female workers non-using PrEP
Description:
Focus group (10 persons)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Transgender women (TGW) non-using PrEP
Description:
Focus group (10 persons)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Healthcare workers in charge of key-populations
Description:
Focus group (10 persons)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Community workers in charge of key-populations
Description:
Focus group (10 persons)
Treatment:
Other: Qualitative assessment about PrEP acceptability
PrEP users
Description:
Focus group (10 persons)
Treatment:
Other: Qualitative assessment about PrEP acceptability
NCHADS
Description:
Individual semi-directive interview (1 person) (NCHADS: operational unit of the Ministry of Health in charge of health sector policy development for HIV/AIDS)
Treatment:
Other: Qualitative assessment about PrEP acceptability
National Aids Authority
Description:
Individual semi-directive interview (1 person) (National Aids Authority: in charge to lead, manage, coordinate and facilitate the comprehensive and multi-sectoral response to HIV and AIDS in Cambodia)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Ministry of Health
Description:
Individual semi-directive interview (1 person)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Key influencer in the MSM and/or TGW community
Description:
Individual semi-directive interview (1 person)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Key influencer in the EW community
Description:
Individual semi-directive interview (1 person)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Khana
Description:
Individual semi-directive interview (1 person) Khana : an umbrella organization belonging to the HIV/AIDS international Alliance
Treatment:
Other: Qualitative assessment about PrEP acceptability
High class and hidden MSM
Description:
Individual semi-directive interview (1 person)
Treatment:
Other: Qualitative assessment about PrEP acceptability
Discontinued PrEP user
Description:
Individual semi-directive interview (1 person)
Treatment:
Other: Qualitative assessment about PrEP acceptability

Trial contacts and locations

1

Loading...

Central trial contact

Vonthanak SAPHONN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems